Kennebec Savings Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9K Hold
114
0.02% 201
2026
Q1
$19.7K Hold
114
0.02% 179
2025
Q4
$22.7K Hold
114
0.02% 184
2025
Q3
$17.8K Buy
114
+5
+5% +$794 0.02% 197
2025
Q2
$16.5K Buy
109
+50
+85% +$6.67K 0.02% 198
2025
Q1
$8.88K Hold
59
0.01% 208
2024
Q4
$11.2K Buy
+59
New +$11.4K 0.01% 208

Other funds holding CRL

Kennebec Savings Bank's CRL Position: Q2 2026 in Review

Kennebec Savings Bank held its Charles River Laboratories (CRL) position steady in Q2 2026 at 114 shares worth $25.9K. The position accounts for 0.02% of the portfolio, ranked #201.

Kennebec Savings Bank first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 133 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Kennebec Savings Bank held 114 shares of Charles River Laboratories worth $25.9K as of Q2 2026.
  • Kennebec Savings Bank left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.02% of Kennebec Savings Bank's portfolio in Q2 2026, its #201 holding.
  • Kennebec Savings Bank first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 133 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.